Clinical Trial Update: AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study [NA]

View source ↗

Summary

A randomized controlled study evaluating an AI-based DeepGEM tool to predict gene mutations in Non-small cell lung cancer patients; the trial status is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Jianxing He | Conditions: Non Small Cell Lung Caner | NA | Status: NOT_YET_RECRUITING